Jefferies Remains Sidelined on Zumiez, Inc. (ZUMZ) Following 4Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Piper Jaffray Cuts Price Target on Zumiez, Inc. (ZUMZ) Following 4Q Report
March 11, 2016 8:04 AM ESTPiper Jaffray maintained a Neutral rating on Zumiez, Inc. (NASDAQ: ZUMZ), and cut the price target to $13.00 (from $17.00), following the company's 4Q earnings report. February sales were reported in tandem with the fourth-quarter conference call, in which comparable store sales declined 8.6% providing near-term perspectives that trends have not yet turned. The company is employing key strategies... More
After-Hours Stock Movers 03/10: (SSKN) (ULTA) (FNSR) Higher; (FXCM) (ZUMZ) (LOCO) Lower (more...)
March 10, 2016 6:02 PM ESTSTRATA Skin Sciences, Inc. (NASDAQ: SSKN) 35.2% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) approved STRATAs PMA supplement for the MelaFind System.
FXCM Inc. (NYSE: FXCM) 18.6% LOWER; Leucadia National Corporation (NYSE: LUK) and FXCM Inc. (NYSE: FXCM) announced that they have entered into a memorandum of understanding (the MOU) to amend the terms of their Amended and Restated Credit Agreement (the Credit Agreement), and... More
Zumiez, Inc. (ZUMZ) Reports In-Line Q4 EPS
March 10, 2016 4:07 PM ESTZumiez, Inc. (NASDAQ: ZUMZ) reported Q4 EPS of $0.50, in-line with the analyst estimate of $0.50. Revenue for the quarter came in at $242.4 million versus the consensus estimate of $241.1 million.
Comparable sales for the 13-week period ended January 30, 2016 decreased 9.5% compared to an 8.3% increase for the 13-week period... More
Trading Radar for 3/10: Dollar General (DG), Canadian Solar (CSIQ), Plug Power (PLUG), Veifone (PAY) Report
March 9, 2016 2:56 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
BioLineRx (Nasdaq: BLRX) - consensus loss $0.06
CECO Environmental (Nasdaq: CECE) - consensus EPS $0.21
Canadian Solar (Nasdaq: CSIQ) - consensus EPS $0.76
Cantel Medical (NYSE: CMN) - consensus EPS $0.34
Cardiome Pharma (Nasdaq:... More
